![Ian Tomlinson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ian Tomlinson
Chairman at
Start Codon Ltd.
Profile
Ian Tomlinson is the founder of Domantis Ltd., which was founded in 2001.
He served as the Chief Scientific Officer from 2001 to 2007.
Currently, he is the Chairman of Start Codon Ltd. since 2019.
He also holds director positions at Human Genome Sciences, Inc., The Bioindustry Association, Apollo Therapeutics LLP, and Apollo Therapeutics Group Ltd. Dr. Tomlinson was the Chairman of Stevenage Bioscience Catalyst from 2015 to 2020 and the Chairman of Maxion Therapeutics Ltd. from 2022 to 2023.
He was also a former director at ViiV Healthcare Ltd. and a former principal at MRC Laboratory of Molecular Biology.
Dr. Tomlinson received his undergraduate degree from Trinity College, Cambridge.
Ian Tomlinson active positions
| Companies | Position | Start |
|---|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Director/Board Member | - |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services Operates as a association to encourage and promote bioscience sector | Director/Board Member | - |
Start Codon Ltd.
 Start Codon Ltd. Investment ManagersFinance Start Condon invest in private companies located in the United Kingdom. The firm focuses on the healthcare sector. It participates in seed, early and later stage capital requirements with an investment size of GBP 250,000. | Chairman | 2019-04-23 |
Apollo Therapeutics LLP
 Apollo Therapeutics LLP Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Director/Board Member | - |
Apollo Therapeutics Group Ltd.
 Apollo Therapeutics Group Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for industrial drug discovery | Director/Board Member | - |
Former positions of Ian Tomlinson
| Companies | Position | End |
|---|---|---|
Maxion Therapeutics Ltd.
 Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures protein therapeutics for cardiovascular, autoimmune and chronic disorders | Chairman | 2023-09-20 |
Stevenage Bioscience Catalyst
 Stevenage Bioscience Catalyst BiotechnologyHealth Technology Operates as open innovation biomedical catalyst | Chairman | 2020-08-31 |
Domantis Ltd.
 Domantis Ltd. Pharmaceuticals: MajorHealth Technology Develops domain antibody therapeutics for treating highly unmet diseases | Founder | 2006-12-31 |
MRC Laboratory of Molecular Biology
 MRC Laboratory of Molecular Biology Miscellaneous Commercial ServicesCommercial Services Provides biological research and development services | Corporate Officer/Principal | - |
| ░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Ian Tomlinson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
18
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Domantis Ltd.
Domantis Ltd. Pharmaceuticals: MajorHealth Technology Develops domain antibody therapeutics for treating highly unmet diseases | Health Technology |
Trinity College, Cambridge
 Trinity College, Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Bioindustry Association
The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services Operates as a association to encourage and promote bioscience sector | Commercial Services |
MRC Laboratory of Molecular Biology
MRC Laboratory of Molecular Biology Miscellaneous Commercial ServicesCommercial Services Provides biological research and development services | Commercial Services |
Stevenage Bioscience Catalyst
Stevenage Bioscience Catalyst BiotechnologyHealth Technology Operates as open innovation biomedical catalyst | Health Technology |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Start Codon Ltd.
Start Codon Ltd. Investment ManagersFinance Start Condon invest in private companies located in the United Kingdom. The firm focuses on the healthcare sector. It participates in seed, early and later stage capital requirements with an investment size of GBP 250,000. | Finance |
Apollo Therapeutics LLP
Apollo Therapeutics LLP Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Maxion Therapeutics Ltd.
Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures protein therapeutics for cardiovascular, autoimmune and chronic disorders | Health Technology |
Apollo Therapeutics Group Ltd.
Apollo Therapeutics Group Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for industrial drug discovery | Health Technology |
- Stock Market
- Insiders
- Ian Tomlinson
